Clinical Trials Logo

Chronic Bronchitis clinical trials

View clinical trials related to Chronic Bronchitis.

Filter by:
  • Active, not recruiting  
  • « Prev · Page 2

NCT ID: NCT02154568 Active, not recruiting - Healthy Clinical Trials

Study of Airflow in the Lungs Using Helium MRI

Start date: November 2013
Phase: N/A
Study type: Interventional

Computer simulations are being developed to predict air flow abnormalities in the airways of patients with lung disease. The purpose of this study is to obtain actual gas flow measurements in the lungs of healthy patients and patients with lung disease and use these measurements to validate the computer models.

NCT ID: NCT02087761 Active, not recruiting - Pneumonia Clinical Trials

A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients

Start date: December 2015
Phase: N/A
Study type: Observational

The ARIES Flu Assay is a real-time PCR based qualitative assay for the direct detection and differentiation of respiratory viral nucleic acid in nasopharyngeal swabs specimens. The objective of this study is to establish the diagnostic accuracy of ARIES Flu Assay.

NCT ID: NCT01969344 Active, not recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Study of COPD Subgroups and Biomarkers

SPIROMICS
Start date: November 2010
Phase:
Study type: Observational

SPIROMICS I and SPIROMICS II are observational studies of Chronic Obstructive Pulmonary Disease (COPD). SPIROMICS I had two main aims: (1) To find groups of patients with COPD who share certain characteristics; (2) To find new ways of measuring whether or not COPD is getting worse and so provide new ways of testing whether a new treatment is working. SPIROMICS II has three primary aims. Aim 1 is to define the natural history of "Smokers with symptoms despite preserved spirometry" and characterize the airway mucus abnormalities underlying this condition. Aim 2 is to determine the radiographic precursor lesion(s) for emphysema, and identify the molecular phenotypes underlying airway disease and emphysema. Aim 3 is to advance understanding of the biology of COPD exacerbations through analysis of predisposing baseline phenotypes, exacerbation triggers and host inflammatory response.

NCT ID: NCT00720226 Active, not recruiting - COPD Clinical Trials

Efficacy of Losartan in Preventing Progression of COPD

Start date: July 2008
Phase: Phase 4
Study type: Interventional

Evidence in animals shows that losartan can prevent or reverse inflammation and lung damage due to smoking. The goal of this study is to determine whether this drug which is also used to treat hypertension can stabilize or improve lung function in people who have from chronic obstructive pulmonary disease (COPD).

NCT ID: NCT00608764 Active, not recruiting - Clinical trials for Pulmonary Disease, Chronic Obstructive

Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)

COPDGene
Start date: November 2007
Phase:
Study type: Observational

Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking. The purpose of this study is to evaluate whether certain genetic factors predispose some smokers to develop COPD more than others.